跳至主要内容
临床试验/NL-OMON42402
NL-OMON42402已完成不适用

A clinical prospective feasibility study to address the effectiveness and safety of calciumphosphate/poly(lactic-co-glycolic-acid) for bone augmentation in maxillary sinus floor elevation surgery. - A clinical feasibility study on the effectivenes and safety of CPC-PLGA.

niversitair Medisch Centrum Sint Radboud0 个研究点目标入组 11 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
11

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Healthy male or female patients aged 18-70 years
  • - Patient qualifies for sinus floor elevation surgery
  • - Presence of a maxillary, unilateral or bilateral, (partial) edentulous area involving the premolar and/or molar area
  • - Presence of a residual alveolar ridge height between 3 and 6 mm

排除标准

  • - Maxillary sinus pathology
  • - Recent extractions in the involved area
  • - Presence of a local or systemic disease or treatment affecting bone formation
  • - Contamination of the (area around the) operative field
  • - Infectious diseases
  • - Bone metabolic disease
  • - Neurological disorders that could influence mental validity
  • - Pregnant or breast-feeding female patients
  • - Patients undergoing cancer therapy including immune suppression, chemotherapy and radiation
  • - Patients with a history of implant failure
  • - Previous entry into this study or participation in any other clinical trial within 30 days

研究者

发起方
niversitair Medisch Centrum Sint Radboud

相似试验